{"schema_version":"1","generated_at":"2026-11-05T07:48:23.015Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/jeffrey-rosenfeld","json_url":"https://www.findmykol.com/kol/jeffrey-rosenfeld/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"jeffrey-rosenfeld","name":"Jeffrey Rosenfeld","credential":"MD","title":"Professor of Neurology and Associate Chairman of Department of Neurology, Loma Linda University School of Medicine","specialty":"Neuromuscular Medicine","specialty_raw":"Neuromuscular Medicine","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"Loma Linda University School of Medicine","institution_url":"https://www.findmykol.com/institution/loma-linda-university-school-of-medicine","city":"Fresno","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1811912348","orcid":"0000-0003-4327-7774","openalex":"A5102925672"},"summary":"Jeffrey Rosenfeld is Professor of Neurology and Associate Chairman of Department of Neurology, Loma Linda University School of Medicine at Loma Linda University School of Medicine. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"Jeffrey Rosenfeld, MD, is Professor of Neurology and Associate Chairman of Department of Neurology, Loma Linda University School of Medicine. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 17 companies.","bullets":["4 registered trials on ClinicalTrials.gov","Open Payments reporting from 17 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"ALS","therapeutic_area":"Neurology","trials":4,"topics":0,"strength":13},{"label":"Motor Neuron Disease","therapeutic_area":"Neurology","trials":3,"topics":0,"strength":9},{"label":"Muscular Atrophy","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Muscular Atrophy, Spinal","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Atrophy","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Paralysis","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Bulbo-Spinal Atrophy, X-Linked","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Bulbar Palsy, Progressive","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Alzheimer's / Dementia","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Migraine / Headache","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"CIDP / Inflammatory Neuropathy","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Multiple Sclerosis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1}],"research_topics":[],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Soliris","generic":"Eculizumab","trials":0,"payments":1,"publications":3,"mentions":4},{"name":"Vyvgart","generic":"Efgartigimod alfa","trials":0,"payments":118,"publications":0,"mentions":118},{"name":"Vyvgart Hytrulo","generic":"Efgartigimod alfa / hyaluronidase","trials":0,"payments":50,"publications":0,"mentions":50}]},"works_with":{"total":20,"shown":3,"withheld":17,"rows":[{"name":"Argenx Us, Inc.","trials":0,"payments":170,"mentions":170},{"name":"Amylyx Pharmaceuticals, Inc.","trials":0,"payments":31,"mentions":31},{"name":"Mitsubishi Tanabe Pharma America, Inc.","trials":0,"payments":28,"mentions":28}]}},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05966038","title":"ALS/MND Natural History Study Data Repository","status":"RECRUITING","role":"Investigator","sponsor":"Massachusetts General Hospital","source_url":"https://clinicaltrials.gov/study/NCT05966038","trial_url":"https://www.findmykol.com/trial/NCT05966038"},{"nct":"NCT04097158","title":"Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone","status":"RECRUITING","role":"Investigator","sponsor":"Loma Linda University","source_url":"https://clinicaltrials.gov/study/NCT04097158","trial_url":"https://www.findmykol.com/trial/NCT04097158"},{"nct":"NCT00070993","title":"Creatine for the Treatment of Amyotrophic Lateral Sclerosis","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"National Center for Complementary and Integrative Health (NCCIH)","source_url":"https://clinicaltrials.gov/study/NCT00070993","trial_url":"https://www.findmykol.com/trial/NCT00070993"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":2025},"rows_total":36,"shown":3,"withheld":33,"rows":[{"payer":"ARGENX US, INC.","program_year":2025,"amount_usd":50173.97,"payment_count":45,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811912348"},{"payer":"UCB, Inc.","program_year":2025,"amount_usd":9637.57,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811912348"},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":6595.46,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811912348"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1811912348","source":"payments"},"funding":{"award_count":0,"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"R01AT000967","title":"CREATINE IN AMYOTROPHIC LATERAL SCLEROSIS","fiscal_year":2004,"amount_usd":303409,"organization":"CAROLINAS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01AT000967"},{"project":"R01AT000967","title":"CREATINE IN AMYOTROPHIC LATERAL SCLEROSIS","fiscal_year":2003,"amount_usd":394411,"organization":"CAROLINAS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01AT000967"},{"project":"R01AT000967","title":"CREATINE IN AMYOTROPHIC LATERAL SCLEROSIS","fiscal_year":2002,"amount_usd":427285,"organization":"CAROLINAS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01AT000967"}],"source":"grants"},"congress":{"count":3,"years":{"first":2024,"last":2026},"societies":["AAN"],"shown":3,"withheld":0,"rows":[{"title":"A New Diagnostic Biomarker in the Study of Amyotrophic Lateral Sclerosis (P10-9.002)","society":"AAN","meeting":"AAN Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1212/wnl.0000000000216486","source_url":"https://doi.org/10.1212/wnl.0000000000216486","status":"verified"},{"title":"Shifting The PARADIGM: PrimeC, An Oral Candidate For Amyotrophic Lateral Sclerosis, Demonstrates Safety, Efficacy, And Target Engagement In An 18-Month Phase 2b Trial (S27.008)","society":"AAN","meeting":"AAN Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1212/wnl.0000000000211098","source_url":"https://doi.org/10.1212/wnl.0000000000211098","status":"verified"},{"title":"Diagnosis of Lambert-Eaton Myasthenic Syndrome (LEMS) May Be Missed Among Patients with Myasthenia Gravis and Autonomic Dysfunction: Results from a US Database Analysis (P4-11.018)","society":"AAN","meeting":"AAN Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1212/wnl.0000000000206220","source_url":"https://doi.org/10.1212/wnl.0000000000206220","status":"verified"}],"source":"congress"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"most_cited":{"total":25,"shown":5,"withheld":20,"rows":[{"title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria","year":2017,"cited_by_count":905,"type":"article","source_url":"https://doi.org/10.1080/21678421.2016.1267768"},{"title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","year":2017,"cited_by_count":845,"type":"article","source_url":"https://doi.org/10.1016/s1474-4422(17)30369-1"},{"title":"Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)[RETIRED]","year":2009,"cited_by_count":807,"type":"article","source_url":"https://doi.org/10.1212/wnl.0b013e3181bc0141"},{"title":"Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)","year":2009,"cited_by_count":674,"type":"article","source_url":"https://doi.org/10.1212/wnl.0b013e3181bc01a4"},{"title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial","year":2014,"cited_by_count":241,"type":"article","source_url":"https://doi.org/10.1016/s1474-4422(14)70222-4"}]},"source":"works"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Carlayne E. Jackson","coauthored_works":14},{"name":"Jonathan Katz","coauthored_works":14,"profile_url":"https://www.findmykol.com/kol/jonathan-katz"},{"name":"Jeremy M. Shefner","coauthored_works":12}],"source":"works"},"presence":{"mentions":{"total":4,"shown":3,"rows":[{"url":"https://als.org/support/certified-centers-clinics/loma-linda-university-als-mnd-program-center-restorative","platform":"other","status":"verified"},{"url":"https://experts.llu.edu/en/persons/jeffrey-rosenfeld/","platform":"other","status":"verified"},{"url":"https://murrieta.lluh.org/provider/rosenfeld-jeffrey","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"MD","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"},{"value":"PhD","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"},{"value":"FAAN (Fellow of the American Academy of Neurology)","source_url":"https://als.org/support/certified-centers-clinics/loma-linda-university-als-mnd-program-center-restorative","status":"verified","collected_at":"2026-11-04"}]},"roles":{"total":4,"shown":3,"rows":[{"value":"Director of the Neuromuscular ALS/MND Program at Loma Linda University (since June 2015)","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"},{"value":"Medical Director of the Center for Restorative Neurology at Loma Linda University","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"},{"value":"Founding Director of the fellowship in Neurotherapeutics at Loma Linda University Health","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Scientific Advisory Board Member, NeuroSense Therapeutics","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"},{"value":"Formerly Chief of Neurology, UCSF Fresno Program","source_url":"https://www.neurosense-tx.com/team-1/prof-jeffery-rosenfeld/","status":"verified","collected_at":"2026-11-04"}]},"media":{"total":2,"shown":2,"rows":[{"value":"Evening Rounds Podcast, Loma Linda University Health - featured speaker on neuromuscular disease and ALS care","source_url":"https://lluh.org/patients-visitors/health-wellness/evening-rounds-podcast/replacing-fear-hope-caring-patients-neuromuscular-disease","status":"verified","collected_at":"2026-11-04"},{"value":"Webinar presenter - 'Finding Hope: A Physician's Perspective on Emotions and Managing ALS', ALS Network","source_url":"https://alsnetwork.org/local/the-center-for-restorative-neurology-at-loma-linda-university-neurology/","status":"provisional","collected_at":"2026-11-04"}]}},"similar":[{"name":"Khashayar Dashtipour","slug":"khashayar-dashtipour","institution":"Loma Linda University School of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/khashayar-dashtipour","json_url":"https://www.findmykol.com/kol/khashayar-dashtipour/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":33,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-04"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-04"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}